LBPWQ (4d pharma) Issuance of Debt: $0.00 Mil (TTM As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LBPWQ 4d pharma PLC LBPWQ
34 GF Score
Price $0.00
! 9 Warning Signs
View Full Analysis

What is 4d pharma Issuance of Debt?

4d pharma LBPWQ 34 Issuance of Debt is $0.00 Mil as of Dec. 2021. GuruFocus rates LBPWQ with a GF Score™ of 34/100. The stock has 9 warning signs investors should review.

4d pharma's Issuance of Debt for the six months ended in Dec. 2021 was $0.00 Mil.

4d pharma's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.

4d pharma Issuance of Debt Related Terms

4d pharma Issuance of Debt Historical Data

* Premium members only.

The historical data trend for 4d pharma's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4d pharma Issuance of Debt Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Issuance of Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.25 12.19

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LBPWQ
34GF Score
4d pharma PLC LBPWQ
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4d pharma Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $0.00 Mil mean?
4d pharma (LBPWQ) has a Issuance of Debt of $0.00 Mil as of Dec. 2021. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on 4d pharma and its competitors.
Is 4d pharma's Issuance of Debt too high?
4d pharma's current Issuance of Debt is $0.00 Mil. Overall, 4d pharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does 4d pharma's Issuance of Debt compare to REGN and VRTX?
4d pharma's Issuance of Debt of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on 4d pharma and its competitors. 4d pharma's current Issuance of Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4d pharma stock overvalued right now?
4d pharma (LBPWQ) has a current Issuance of Debt of $0.00 Mil. The current Issuance of Debt is $0.00 Mil. 4d pharma's overall GF Score™ is 34/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For 4d pharma (LBPWQ), the current Issuance of Debt is $0.00 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4d pharma Business Description

Address 9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
34GF Score

Get the complete analysis for LBPWQ

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price